Literature DB >> 17548794

Clinical applications of Silybum marianum in oncology.

Heather Greenlee1, Kathy Abascal, Eric Yarnell, Elena Ladas.   

Abstract

Milk thistle (Silybum marianum) is an herb that is increasingly used in oncology research and treatment settings. Historically, it has been used to treat liver and biliary disorders and has been used in detoxification and cleansing protocols. However, milk thistle is increasingly being investigated for its use in adult and pediatric populations for oncology indications. Possible indications during cancer treatment include cleansing and detoxification after chemotherapy, preventing hepatotoxicity during chemotherapy, treating hepatotoxicity after chemotherapy, and potentiating chemotherapy and radiation therapy as an adjunctive treatment. Milk thistle may also have applications in ameliorating long-term hepatic and cardiovascular effects of cancer treatment. Preliminary studies are investigating its use as a chemopreventive agent and possibly to treat cancer directly. Much of milk thistle's current clinical use grows out of historical uses but is informed by an increasing number of clinical trials and animal studies. This article provides an overview of the current clinical applications of milk thistle in the oncology setting, including guidelines on commonly used forms and doses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17548794     DOI: 10.1177/1534735407301727

Source DB:  PubMed          Journal:  Integr Cancer Ther        ISSN: 1534-7354            Impact factor:   3.279


  12 in total

Review 1.  Food-based natural products for cancer management: Is the whole greater than the sum of the parts?

Authors:  Suleman S Hussain; Addanki P Kumar; Rita Ghosh
Journal:  Semin Cancer Biol       Date:  2016-07-07       Impact factor: 15.707

2.  A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL).

Authors:  Elena J Ladas; David J Kroll; Nicholas H Oberlies; Bin Cheng; Deborah H Ndao; Susan R Rheingold; Kara M Kelly
Journal:  Cancer       Date:  2010-01-15       Impact factor: 6.860

Review 3.  Botanicals and Their Bioactive Phytochemicals for Women's Health.

Authors:  Birgit M Dietz; Atieh Hajirahimkhan; Tareisha L Dunlap; Judy L Bolton
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

Review 4.  Multitargeted therapy of cancer by silymarin.

Authors:  Kumaraguruparan Ramasamy; Rajesh Agarwal
Journal:  Cancer Lett       Date:  2008-05-09       Impact factor: 8.679

5.  Effects of aqueous extract from Silybum marianum on adenosine deaminase activity in cancerous and noncancerous human gastric and colon tissues.

Authors:  Bahadır Öztürk; Ender Hilmi Kocaoğlu; Zahide Esra Durak
Journal:  Pharmacogn Mag       Date:  2015 Jan-Mar       Impact factor: 1.085

6.  Gestational Exposure to Silymarin Increases Susceptibility of BALB/c Mice Fetuses to Apoptosis.

Authors:  Mahbobe Gholami; Seyed Adel Moallem; Mohammad Afshar; Leila Etemad; Gholamreza Karimi
Journal:  Avicenna J Med Biotechnol       Date:  2017 Apr-Jun

7.  Optimization of Microwave-assisted Extraction of Silymarin from Silybum marianum Straws by Response Surface Methodology and Quantification by High-Performance Liquid Chromatograph Method.

Authors:  Hong-Sheng Ruan; Hai-Feng Zhang; Kun Teng
Journal:  Pharmacogn Mag       Date:  2018-02-20       Impact factor: 1.085

8.  The protective effects of silymarin against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats.

Authors:  Aleksandar Rašković; Nebojša Stilinović; Jovanka Kolarović; Velibor Vasović; Saša Vukmirović; Momir Mikov
Journal:  Molecules       Date:  2011-10-12       Impact factor: 4.411

9.  Optimization and single-laboratory validation of a method for the determination of flavonolignans in milk thistle seeds by high-performance liquid chromatography with ultraviolet detection.

Authors:  Elizabeth Mudge; Lori Paley; Andreas Schieber; Paula N Brown
Journal:  Anal Bioanal Chem       Date:  2015-07-31       Impact factor: 4.142

10.  Effects of Oral Administration of Silymarin in a Juvenile Murine Model of Non-alcoholic Steatohepatitis.

Authors:  Veronica Marin; Silvia Gazzin; Sabrina E Gambaro; Matteo Dal Ben; Sonia Calligaris; Monica Anese; Alan Raseni; Claudio Avellini; Pablo J Giraudi; Claudio Tiribelli; Natalia Rosso
Journal:  Nutrients       Date:  2017-09-12       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.